Bhagirathbhai Dholaria

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Travel
    Ineligible company: 
    Janssen
    Date added: 
    08/09/2023
    Relationship end date: 
    06/06/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    ADC therapeutics
    Date added: 
    08/09/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Arivan
    Date added: 
    08/09/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    MJH bio
    Date added: 
    08/09/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Pfizer
    Date added: 
    08/09/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    BMS
    Date added: 
    08/09/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Gilead
    Date added: 
    08/09/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Angiocrine
    Date added: 
    08/09/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Wugen
    Date added: 
    08/09/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Takeda
    Date added: 
    08/09/2023

Pages

Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice